Profile
Gary S.
Titus is currently a Director at BioSight Ltd. He previously worked as a Senior Finance Director at IntraBiotics Pharmaceuticals, Inc. and CymaBay Therapeutics, Inc. He was also the Chief Financial Officer & Senior Vice President at SciClone Pharmaceuticals LLC, Chief Financial & Accounting Officer, VP at Nuvelo, Inc., and Chief Financial Officer & Senior Vice President at Kosan Biosciences, Inc. He served as an Independent Director at ImmunoCellular Therapeutics Ltd. and was the Chief Financial Officer at BioCardia, Inc. and UroGen Pharma Ltd. He holds an undergraduate degree from the University of Florida and the University of South Florida.
Gary Titus active positions
| Companies | Position | Start |
|---|---|---|
BioSight Ltd.
BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Director/Board Member | - |
Former positions of Gary Titus
| Companies | Position | End |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Director of Finance/CFO | 05/07/2019 |
| UROGEN PHARMA LTD. | Director of Finance/CFO | 05/06/2018 |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Director of Finance/CFO | 01/01/2015 |
| SCICLONE PHARMACEUTICALS, INC. | Director of Finance/CFO | 31/05/2013 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Director of Finance/CFO | 01/09/2008 |
Training of Gary Titus
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
SciClone Pharmaceuticals LLC
SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer and infectious diseases | Health Technology |
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
ImmunoCellular Therapeutics Ltd.
ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Health Technology |
BioSight Ltd.
BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Health Technology |
UroGen Pharma Ltd.
UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
- Stock Market
- Insiders
- Gary Titus
















